English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18076/20274 (89%)
造訪人次 : 5274787      線上人數 : 1058
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34441


    標題: The Use of Propofol versus Dexmedetomidine for Patients Receiving Drug-Induced Sleep Endoscopy: A Meta-Analysis of Randomized Controlled Trials
    作者: Chen, Yi-Ting
    Sun, Cheuk-Kwan
    Wu, Kuan-Yu
    Chang, Ying-Jen
    Chiang, Min-Hsien
    Chen, I-Wen
    Liao, Shu-Wei
    Hung, Kuo-Chuan
    貢獻者: Chia Yi Chang Gung Mem Hosp, Dept Anesthesiol
    E Da Hosp, Dept Emergency Med
    I Shou Univ, Coll Med
    Natl Cheng Kung Univ Hosp, Dept Urol
    Natl Cheng Kung Univ, Coll Med
    Chi Mei Med Ctr, Dept Anesthesiol
    Chang Jung Christian Univ, Coll Hlth Sci
    Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Coll Med
    Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr
    關鍵字: dexmedetomidine
    propofol
    drug-induced sleep endoscopy
    hypoxemia
    日期: 2021
    上傳時間: 2023-11-11 11:53:01 (UTC+8)
    出版者: MDPI
    摘要: The sedation outcomes associated with dexmedetomidine compared with those of propofol during drug-induced sleep endoscopy (DISE) remains unclear. Electronic databases (i.e., the Cochrane controlled trials register, Embase, Medline, and Scopus) were searched from inception to 25 December 2020 for randomized controlled trials (RCTs) that evaluated the sedation outcomes with dexmedetomidine or propofol in adult patients diagnosed with obstructive sleep apnea (OSA) receiving DISE. The primary outcome was the difference in minimum oxygen saturation (mSaO2). Five RCTs (270 participants) published between 2015 and 2020 were included for analysis. Compared with dexmedetomidine, propofol was associated with lower levels of mSaO2 (mean difference (MD) = -7.24, 95% confidence interval (CI) -12.04 to -2.44; 230 participants) and satisfaction among endoscopic performers (standardized MD = -2.43, 95% CI -3.61 to -1.26; 128 participants) as well as a higher risk of hypoxemia (relative ratios = 1.82, 95% CI 1.2 to 2.76; 82 participants). However, propofol provided a shorter time to fall asleep and a lower risk of failed sedation compared with dexmedetomidine. No significant difference was found in other outcomes. Compared with propofol, dexmedetomidine exhibited fewer adverse effects on respiratory function and provided a higher level of satisfaction among endoscopic performers but was associated with an elevated risk of failed sedation.
    關聯: J CLIN MED, v.10, n.8, pp.1585
    顯示於類別:[保健營養系(所) ] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    index.html0KbHTML293檢視/開啟
    jcm10081585.pdf3231KbAdobe PDF129檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋